Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Pilot, Phase II , Open Label, Nonrandomized, Multi- Center Study of [F 18]HX4 Positron Emission Tomography (PET) to Detect Hypoxia in Tumors

NCT01075399 is registered in ClinicalTrials.gov with Siemens Molecular Imaging as lead sponsor.

NCT NCT01075399
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01075399 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Pilot, Phase II , Open Label, Nonrandomized, Multi- Center Study of [F 18]HX4 Positron Emission Tomography (PET) to Detect Hypoxia in Tumors
Lead sponsor
Siemens Molecular Imaging
Phase
Phase 2
Overall status
Completed
Start date
February 28, 2010
Completion date
February 29, 2012
Enrollment
50 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

cervical cancer, head and neck cancer, liver cancer, lung cancer, rectal cancer